Lite Access Technologies Inc (LA7) ニュース

The last update I read said expect the change to come in early 2025. Nothing more specific.

...no more bell ringing on CNBC.

He is not confusing the P2a and P2b/3 AD trials and data. He is also right that according to Missling data from both trials is part of the MAA submission.

There is no change in the share structure. I was surprised considering the volume last week.

Oh, a little different, but that’s the quote people have been discussing. I see thanks.

I found that quote, and I like what she had to say right after that quote at the June 29, 2024 ASM.


Second, comment is; there's no guarantees. I have to say this again, but w

This is the ONE !! Zip Code Changer 
Get your Moon Pants On $$$$$$$

RE-COIL DAY !!
The Full Socatics line has crossed and the CCI line has shown reversal and heading back to support! We should see continued upswing today and setup for the next leg up and over the next week back over $3 for both Fannie and Freddie.
https://investorshub.advfn.com/uimage

A very promising 2025 is ahead for investors after listening to the Bloomberg report. $SGTM

Damn eagles the ravens did enough to win that game but Justin tucker the one time goat of a kicker left 7 points on the field if he had made just two out of the three he missed the ravens would have won inspite of the great defense of the eagles. I don't see the chiefs beating the eagles if they bot

Morning all!

🐔

It´s very disturbing that a post is been deleted that pointed out that someone called with Lebby and there´s nothing on the horizon and Walter also knows about this?? Why is that post removed?? If this turns out to be true in the end, that wouldn´t be good!!

It is a good and balanced article that points out too what some including me has said about the “quirky” ways Anavex tends to present data and lack of it in the face strictly failed trials.

Some, or perhaps even many here do not agree, but one thing is clear and that of course is that

Just locked in gains and moving on to other opportunities with better risk/reward, especially in the next 3-6 months. Just keeping in mind the dot com bust and 2008-2009. Nothing goes straight up, even SOUN.😊

Top 15 at 7:15
https://ih.advfn.com/markets/nasdaq/premarket

$ADHC is poised for growth with the addition of Glucoguard and FDA Breakthrough Therapy designation. https://youtu.be/j-_szaDsAts?si=vbVjdSvUiqcJFidi "American Diversified Holdings Corp (ADHC) and its Game-Changing Acquisition of GlucoGuard: A Leap Towards Revolutionizing Diabetic Care"

RE-COIL DAY !!
The Full Socatics line has crossed and the CCI line has shown reversal and heading back to support! We should see continued upswing today and setup for the next leg up and over the next week back over $3 for both Fannie and Freddie.
https://investorshub.advfn.com/uimage

$ADHC is poised for growth with the addition of Glucoguard and FDA Breakthrough Therapy designation. https://youtu.be/j-_szaDsAts?si=vbVjdSvUiqcJFidi "American Diversified Holdings Corp (ADHC) and its Game-Changing Acquisition of GlucoGuard: A Leap Towards Revolutionizing Diabetic Care"

.127 ~Rig

Sure is, lolol ~Rig

billion per day in dilution...weeee super stock

Nice sounds fun ,bow hunting bucks in Oregon until December 15 on the Oregon dunes just in from the beach

🏆️ The Tesla Model Y 2024 has been awarded IIHS’s “top safety pick +” 🏆️ award from the Insurance Institute for Highway Safety (IIHS) despite more stringent eligibility..

https://electrek.co/2024/02/27/tesla-model-y-2024-scores-near-perfect-iihs-crash-tests/#:~:text=Th

'I’ve also been mindful of saving on health expenses. Canadian pharmacy has been a reliable option for affordable medications and supplements, which helps free up more budget for other things—like exploring stock opportunities'....lol hahaha! a clickbait epic fail. How weak and silly.

C4 Therapeutics Presents Cemsidomide Phase 1 Data at the American Society for Hematology (ASH) Annual Meeting that Demonstrated Potential to Become Best-in-Class IKZF1/3 Degrader
In Multiple Myeloma, Cemsidomide in Combination with Dexamethasone at Highest Dose Level Explored to Date Achieved